Publications by authors named "Silvio B Santos"

Article Synopsis
  • Staphylococcus aureus is a major cause of mastitis in dairy cattle, with rising antimicrobial resistance posing threats to both animal and human health.
  • The jumbo phage vB_SauM-UFV_DC4 was studied for its ability to kill S. aureus and was found to be stable in a range of pH levels.
  • DC4's complete genome revealed it as a new species with unique proteins and potential biotechnological applications, as it shares similarities with other jumbo phages.
View Article and Find Full Text PDF

Salmonella Enteritidis is the main serotype responsible for human salmonellosis in the European Union. One of the main sources of Salmonella spp. in the food chain are poultry products, such as eggs or chicken meat.

View Article and Find Full Text PDF

Antimicrobial resistance (AMR) is considered one of the greatest threats to global health. Methicillin-resistant (MRSA) remains at the core of this threat, accounting for about 90% of infections widespread in the community and hospital settings. In recent years, the use of nanoparticles (NPs) has emerged as a promising strategy to treat MRSA infections.

View Article and Find Full Text PDF
Article Synopsis
  • The text discusses the link between certain gastric diseases and the need for effective diagnostic methods due to their global prevalence.
  • It categorizes available diagnostic techniques into invasive (like endoscopy and culture) and non-invasive (like breath tests and serological assays), and highlights their respective pros and cons.
  • The review also touches on emerging diagnostic innovations, including bacteriophage-based tools, aimed at improving the detection and monitoring of these gastric conditions.
View Article and Find Full Text PDF

Bacterial pathogens are progressively adapting to current antimicrobial therapies with severe consequences for patients and global health care systems. This is critically underscored by the rise of methicillin resistant Staphylococcus aureus (MRSA) and other biofilm-forming staphylococci. Accordingly, alternative strategies have been explored to fight such highly multidrug resistant microorganisms, including antimicrobial photodynamic therapy (aPDT) and phage therapy.

View Article and Find Full Text PDF
Article Synopsis
  • The study focuses on a newly isolated phage called 3043-K38 that targets a specific capsule type (K38) in a species known for being resistant to antibiotics and often associated with hospital infections.
  • The phage carries a unique depolymerase enzyme that can break down the protective capsule, making the bacteria more vulnerable to immune attacks.
  • This research emphasizes the potential of using this phage and its depolymerase as a new strategy to combat drug-resistant bacterial infections in clinical settings.
View Article and Find Full Text PDF

is a Gram-negative bacterium that has become one of the leading causes of life-threatening healthcare-associated infections (HAIs), including pneumonia and sepsis. Moreover, due to its increasingly antibiotic resistance, has been declared a global top priority concern. The problem of infections is due, in part, to the inability to detect this pathogen rapidly and accurately and thus to treat patients within the early stages of infections.

View Article and Find Full Text PDF

Bacteriophages (phages) are ubiquitous entities present in every conceivable habitat as a result of their bacterial parasitism. Their prevalence and impact in the ecology of bacterial communities and their ability to control pathogens make their characterization essential, particularly of new phages, improving knowledge and potential application. The isolation and characterization of a new lytic phage against Sphaerotilus natans strain DSM 6575, named vB_SnaP-R1 (SnaR1), is here described.

View Article and Find Full Text PDF

Although different strategies to control biofilm formation on endotracheal tubes have been proposed, there are scarce scientific data on applying phages for both removing and preventing biofilms on the device surface. Here, the anti-biofilm capacity of five bacteriophages was evaluated by a high content screening assay. We observed that biofilms were significantly reduced after phage treatment, especially in multidrug-resistant strains.

View Article and Find Full Text PDF

Studies involving antimicrobial-coated endotracheal tubes are scarce, and new approaches to control multidrug-resistant biofilm on these devices should be investigated. In this study, five new bacteriophages from domestic sewage were isolated. All of them belong to the order , family.

View Article and Find Full Text PDF

Healthcare-associated infections (HCAIs) affect hundreds of millions of patients, representing a significant burden for public health. They are usually associated to multidrug resistant bacteria, which increases their incidence and severity. Bloodstream infections are among the most frequent and life-threatening HCAIs, with Enterococcus and Staphylococcus among the most common isolated pathogens.

View Article and Find Full Text PDF

Bloodstream infections (BSIs) are considered a major cause of death worldwide. Staphylococcus spp. are one of the most BSIs prevalent bacteria, classified as high priority due to the increasing multidrug resistant strains.

View Article and Find Full Text PDF

Phages have shown a high biotechnological potential with numerous applications. The advent of high-resolution microscopy techniques aligned with omic and molecular tools are revealing innovative phage features and enabling new processes that can be further exploited for biotechnological applications in a wide variety of fields. This special issue is a collection of original and review articles focusing on the most recent advances in phage-based biotechnology with applications for human benefit.

View Article and Find Full Text PDF

and are opportunistic pathogens and are commonly found in polymicrobial biofilm-associated diseases, namely chronic wounds. Their co-existence in a biofilm contributes to an increased tolerance of the biofilm to antibiotics. Combined treatments of bacteriophages and antibiotics have shown a promising antibiofilm activity, due to the profound differences in their mechanisms of action.

View Article and Find Full Text PDF

Bacteriophage endolysins present enormous biotechnological potentials and have been successfully used to control and detect bacterial pathogens. Endolysins targeting Gram-positive bacteria are modular, displaying a cell binding (CBD) and an enzymatically active domain. The CBD of phage endolysins are recognized by their high specificity and host affinity, characteristics that make them promising diagnostic tools.

View Article and Find Full Text PDF

is an important pathogen causative of health care-associated infections and is able to rapidly develop resistance to all known antibiotics, including colistin. As an alternative therapeutic agent, we have isolated a novel myovirus (vB_AbaM_B9) which specifically infects and makes lysis from without in strains of the K45 and K30 capsule types, respectively. Phage B9 has a genome of 93,641 bp and encodes 167 predicted proteins, of which 29 were identified by mass spectrometry.

View Article and Find Full Text PDF

Bacteriophages encode many distinct proteins for the successful infection of a bacterial host. Each protein plays a specific role in the phage replication cycle, from host recognition, through takeover of the host machinery, and up to cell lysis for progeny release. As the roles of these proteins are being revealed, more biotechnological applications can be anticipated.

View Article and Find Full Text PDF

is one of the most relevant opportunistic pathogens involved in many biofilm-associated diseases, and is a major cause of nosocomial infections, mainly due to the increasing prevalence of multidrug-resistant strains. Consequently, alternative methods to eradicate the pathogen are urgent. It has been previously shown that polyvalent staphylococcal kayviruses and their derived endolysins are excellent candidates for therapy.

View Article and Find Full Text PDF

Endolysins, which are peptidoglycan-degrading enzymes expressed during the terminal stage of the reproduction cycle of bacteriophages, have great potential to control Gram-positive pathogens. This work describes the characterization of a novel endolysin (PlyPl23) encoded on the genome of Paenibacillus larvae phage phiIBB_Pl23 with high potential to control American foulbrood. This bacterial disease, caused by P.

View Article and Find Full Text PDF

The prevalence and impact of bacteriophages in the ecology of bacterial communities coupled with their ability to control pathogens turn essential to understand and predict the dynamics between phage and bacteria populations. To achieve this knowledge it is essential to develop mathematical models able to explain and simulate the population dynamics of phage and bacteria. We have developed an unstructured mathematical model using delay-differential equations to predict the interactions between a broad-host-range Salmonella phage and its pathogenic host.

View Article and Find Full Text PDF

Phages are recognized as the most abundant and diverse entities on the planet. Their diversity is determined predominantly by their dynamic adaptation capacities when confronted with different selective pressures in an endless cycle of coevolution with a widespread group of bacterial hosts. At the end of the infection cycle, progeny virions are confronted with a rigid cell wall that hinders their release into the environment and the opportunity to start a new infection cycle.

View Article and Find Full Text PDF